RxDoctor Payments Data

Jenna Galati

Psychiatric/Mental Health · Port Huron, MINPI 1306502117

Payments from drug & device makers

$2,552in general payments, 2019–2025

Across 131 payments — averaging $19.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alkermes, Inc.$708
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$321
  • Neurocrine Biosciences, Inc.$320
  • Otsuka America Pharmaceutical, Inc.$310
  • Teva Pharmaceuticals USA, Inc.$250
  • E.r. Squibb & Sons, L.L.C.$162
  • plus $480 from 7 others

What the payments were for

  • Food & beverage$2,38994%
  • Education$1626%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,552 in reported general payments places this provider in the 80th percentile of 638 psychiatric/mental health providers in Michigan.

See all psychiatric/mental health providers in Michigan

Medicare billing

Part B allowed, 2024
$20,206
Medicare patients
55
Services billed
266

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega TrinzaPaliperidone Palmitate11$114,599
Invega SustennaPaliperidone Palmitate15$47,049
RexultiBrexpiprazole30$44,797
AristadaAripiprazole Lauroxil13$40,277
AustedoDeutetrabenazine13$30,581
VraylarCariprazine Hcl21$29,516
TrintellixVortioxetine Hydrobromide14$11,150
Clozapine46$5,998
Divalproex Sodium ErDivalproex Sodium73$3,529
Lurasidone Hcl37$3,232
Paliperidone ErPaliperidone23$2,619
Clonidine Hcl ErClonidine Hcl15$2,371
Aripiprazole93$2,346
Fluoxetine Hcl127$2,169
Buspirone Hcl90$1,571

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Trinza, Invega Sustenna$144$161,64826 claims
Otsuka America Pharmaceutical, Inc.Rexulti$310$44,79730 claims
Alkermes, Inc.Aristada$708$40,27713 claims
Teva Pharmaceuticals USA, Inc.Austedo$250$30,58113 claims
AbbVieVraylar$85$29,51621 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 638 psychiatric/mental health providers in Michigan.

Other psychiatric/mental health in Port Huron

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →